Viewing Study NCT03235869


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-01-03 @ 10:36 AM
Study NCT ID: NCT03235869
Status: WITHDRAWN
Last Update Posted: 2018-03-15
First Post: 2017-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module